Inhibition of PAX2 Gene Expression by siRNA (Polyethylenimine) in Experimental Model of Obstructive Nephropathy

REFERENCES

• Chen F. Genetic and developmental basis for urinary tract obstruction. Pediatr Nephrol. 2009;24(9):1621–1632.
   PubMed Web of Science ®Google Scholar
• Chevalier RL, Thornhill BA, Forbes MS, Kiley SC. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol. 2010; 25(4):687–697.
   PubMed Web of Science ®Google Scholar
• Picard N, Baum O, Vogetseder A, Kaissling B, Le Hir M. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol. 2008;130(1):141–155.
   PubMed Web of Science ®Google Scholar
• Narlis M, Grote D, Gaitan Y, Boualia SK, Bouchard M. PAX2 and pax8 regulate branching morphogenesis and nephron differentiation in the developing kidney. J Am Soc Nephrol. 2007;18(4):1121–1129.
   PubMed Web of Science ®Google Scholar
• Lindoso RS, Verdoorn KS, Einicker-Lamas M. Renal recovery after injury: The role of Pax-2. Nephrol Dial Transplant. 2009;24(9):2628–2633.
   PubMed Web of Science ®Google Scholar
• Cohen T, Loutochin O, Amin M, Capolicchio JP, Goodyer P, Jednak R. PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death. Am J Physiol Renal Physiol. 2007;292(4):F1267–F1273.
   Web of Science ®Google Scholar
• Li L, Wu Y, Zhang W. PAX2 re-expression in renal tubular epithelial cells and correlation with renal interstitial fibrosis of rats with obstructive nephropathy. Ren Fail. 2010;32(5): 603–611.
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669): 806–811.
   PubMed Web of Science ®Google Scholar
• Hueber PA, Waters P, Clark P, Eccles M, Goodyer P. PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells. Kidney Int. 2006;69(7):1139–1145.
   PubMed Web of Science ®Google Scholar
• Qing L, Quan K, Song W, . Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing. Gene. 2007;395(1–2):160–169.
   PubMed Web of Science ®Google Scholar
• Taal MW, Zandi-Nejad K, Weening B, . Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int. 2000;58(4):1664–1676.
   PubMed Web of Science ®Google Scholar
• Mizuguchi Y, Miyajima A, Kosaka T, Asano T, Asano T, Hayakawa M. Atrovastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol. 2004;172(6 Pt 1): 2456–2459.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T)method. Nat Protoc. 2008;3(6):1101–1108.
   PubMed Web of Science ®Google Scholar
• Moffat J, Sabatini DM. Building mammalian signalling pathways with RNAi screens. Nat Rev Mol Cell Biol. 2006;7(3):177–187.
   PubMed Web of Science ®Google Scholar
• Kumar LD, Clarke AR. Gene manipulation through the use of small interfering RNA (siRNA): From in vitro to in vivo applications. Adv Drug Deliver Rev. 2007;59(2–3):87–100.
   PubMed Web of Science ®Google Scholar
• Wilson R, Purcell D, Netter HJ, Revill PA. Does RNA interference provide new hope for control of chronic hepatitis B infection? Antivir Ther. 2009;14(7):879–889.
   PubMed Web of Science ®Google Scholar
• Bramsen JB, Laursen MB, Nielsen AF, . A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res. 2009;37(9):2867–2881.
   PubMed Web of Science ®Google Scholar
• Ui-Tei K, Naito Y, Zenno S, . Functional dissection of siRNA sequence by systematic DNA substitution: Modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect. Nucleic Acids Res. 2008;36(7):2136–2151.
   PubMed Web of Science ®Google Scholar
• Choung S, Kim YJ, Kim S, Park HO, Choi YC. Chemical modification of siRNAs to improve serum stability without loss of efficacy. Biochem Biophys Res Commun. 2006;342(3):919–927.
   PubMed Web of Science ®Google Scholar
• Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK. RNA interference in the clinic: Challenges and future directions. Nat Rev Cancer. 2011;11(1):59–67.
   PubMed Web of Science ®Google Scholar
• Duan Y, Zhang S, Wang B, Yang B, Zhi D. The biological routes of gene delivery mediated by lipid-based non-viral vectors. Expert Opin Drug Deliv. 2009;6(12):1351–1361.
   PubMed Web of Science ®Google Scholar
• Zaiss AK, Muruve DA. Immune responses to adeno-associated virus vectors. Curr Gene Ther. 2005;5(3):323–331.
   PubMed Web of Science ®Google Scholar
• Karmali PP, Chaudhuri A. Cationic liposomes as non-viral carriers of gene medicines: Resolved issues, open questions, and future promises. Med Res Rev. 2007;27(5):696–722.
   PubMed Web of Science ®Google Scholar
• Behlke MA. Progress towards in vivo use of siRNAs. Mol Ther. 2006;13(4):644–670.
   PubMed Web of Science ®Google Scholar
• Nimesh S, Chandra R. Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system. Eur J Pharm Biopharm. 2009;73(1):43–49.
   PubMed Web of Science ®Google Scholar
• Jere D, Jiang HL, Arote R, . Degradable polyethylenimines as DNA and small interfering RNA carriers. Expert Opin Drug Deliv. 2009;6(8):827–834.
   PubMed Web of Science ®Google Scholar
• Hassani Z, Francois JC, Alfama G, . A hybrid CMV-H1 construct improves efficiency of PEI-delivered shRNA in the mouse brain. Nucleic Acids Res. 2007;35(9):e65.
   Web of Science ®Google Scholar
• Liao HW, Yau KW. In vivo gene delivery in the retina using poly- ethyleneimine. Biotechniques. 2007;42(3):285–6, 288.
   PubMed Web of Science ®Google Scholar
• Bolcato-Bellemin AL, Bonnet ME, Creusat G, Erbacher P, Behr JP. Sticky overhangs enhance siRNA-mediated gene silencing. Proc Natl Acad Sci USA. 2007;104(41):16050–16055.
   PubMed Web of Science ®Google Scholar
• Yoshinari K, Miyagishi M, Taira K. Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res. 2004;32(2):691–699.
   PubMed Web of Science ®Google Scholar